These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8123597)

  • 1. Stable expression of a c-JUN deletion mutant in two malignant mouse epidermal cell lines blocks tumor formation in nude mice.
    Domann FE; Levy JP; Birrer MJ; Bowden GT
    Cell Growth Differ; 1994 Jan; 5(1):9-16. PubMed ID: 8123597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.
    Bowden GT; Schneider B; Domann R; Kulesz-Martin M
    Cancer Res; 1994 Apr; 54(7 Suppl):1882s-1885s. PubMed ID: 8137304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation and inhibition of the AP-1 complex in human breast cancer cells.
    Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
    Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the human NPY gene during neuroblastoma cell differentiation: induced transcriptional activities of AP-1 and AP-2.
    Andersson G; Påhlman S; Parrow V; Johansson I; Hammerling U
    Cell Growth Differ; 1994 Jan; 5(1):27-36. PubMed ID: 8123590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es).
    Farina AR; Cappabianca L; Mackay AR; Tiberio A; Tacconelli A; Tessitore A; Frati L; Martinotti S; Gulino A
    Cell Growth Differ; 1997 Jul; 8(7):789-800. PubMed ID: 9218873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
    Dhar A; Hu J; Reeves R; Resar LM; Colburn NH
    Oncogene; 2004 May; 23(25):4466-76. PubMed ID: 15064752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element.
    Li JJ; Dong Z; Dawson MI; Colburn NH
    Cancer Res; 1996 Feb; 56(3):483-9. PubMed ID: 8564958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
    Jansen AP; Colburn NH; Verma AK
    Oncogene; 1999 Oct; 18(42):5806-13. PubMed ID: 10523861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
    Suzukawa K; Colburn NH
    Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A short region containing an AP-1 binding site is essential for transforming growth factor-beta-induced c-jun gene expression in osteoblastic cells.
    Hata S; Shimizu T; Fujimoto M
    IUBMB Life; 2000 Mar; 49(3):229-34. PubMed ID: 10868915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.
    Agadir A; Shealy YF; Hill DL; Zhang X
    Cancer Res; 1997 Aug; 57(16):3444-50. PubMed ID: 9270011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumorigenic and metastatic properties of two ras-oncogene transfected rat fibrosarcoma cell lines defective in c-jun.
    Marshall-Heyman H; Engel G; Ljungdahl S; Shoshan MC; Svensson C; Wasylyk B; Linder S
    Oncogene; 1994 Dec; 9(12):3655-63. PubMed ID: 7970724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response.
    Li JJ; Westergaard C; Ghosh P; Colburn NH
    Cancer Res; 1997 Aug; 57(16):3569-76. PubMed ID: 9270030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occupancy and composition of proteins bound to the AP-1 sites in the glucocorticoid receptor and c-jun promoters after glucocorticoid treatment and in different cell types.
    Barrett TJ; Vedeckis WV
    Recept Signal Transduct; 1996; 6(3-4):179-93. PubMed ID: 9259052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the urokinase-type plasminogen activator receptor gene in different grades of human glioma cell lines.
    Bhattacharya A; Lakka SS; Mohanam S; Boyd D; Rao JS
    Clin Cancer Res; 2001 Feb; 7(2):267-76. PubMed ID: 11234878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive AP-1 DNA binding and transactivating ability of malignant but not benign mouse epidermal cells.
    Domann FE; Levy JP; Finch JS; Bowden GT
    Mol Carcinog; 1994 Feb; 9(2):61-6. PubMed ID: 8142009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic phorbol ester treatment on protein kinase C activity, content, and gene expression in the human monoblastoid U937 cell.
    Ways DK; Qin W; Garris TO; Chen J; Hao E; Cooper DR; Usala SJ; Parker PJ; Cook PP
    Cell Growth Differ; 1994 Feb; 5(2):161-9. PubMed ID: 8180129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of activator protein-1 (AP-1) in induction of apoptosis by vitamin E succinate in human breast cancer cells.
    Zhao B; Yu W; Qian M; Simmons-Menchaca M; Brown P; Birrer MJ; Sanders BG; Kline K
    Mol Carcinog; 1997 Jul; 19(3):180-90. PubMed ID: 9254885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JunB negatively regulates AP-1 activity and cell proliferation of malignant mouse keratinocytes.
    Finch S; Joseloff E; Bowden T
    J Cancer Res Clin Oncol; 2002 Jan; 128(1):3-10. PubMed ID: 11862466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.